Literature DB >> 1568779

Why do varices bleed?

R de Franchis1, M Primignani.   

Abstract

About one third of cirrhotic patients with esophageal varices eventually bleed from ruptured varices. The incidence of rebleeding is extremely high during the first 6 weeks after the initial bleeding but declines gradually thereafter. Later, the rebleeding risk returns to baseline levels, i.e., equals that of patients who have never bled. The size of varices and the presence of red color signs on the variceal wall are recognized by most investigators as important in assessing the risk of variceal hemorrhage. Prognostic indexes such as the NIEC index, which incorporate the endoscopic signs with clinical data such as the Child-Pugh score, have been shown to predict the probability of first variceal hemorrhage of individual patients reliably. Other important parameters are the presence of ascites and, in alcoholic cirrhotics, the lack of abstinence from alcohol. The presence of endoscopic signs of bleeding or of stigmata of recent bleeding, of large varices, or of liver failure at the time of first bleeding are risk factors for early rebleeding. The most important risk factors for late rebleeding are the presence of large varices, overt signs of hepatic decompensation, the development of hepatocellular carcinoma, and lack of alcohol abstinence.

Entities:  

Mesh:

Year:  1992        PMID: 1568779

Source DB:  PubMed          Journal:  Gastroenterol Clin North Am        ISSN: 0889-8553            Impact factor:   3.806


  19 in total

1.  Role of interventional radiology in the emergent management of acute upper gastrointestinal bleeding.

Authors:  Rakesh Navuluri; Jay Patel; Lisa Kang
Journal:  Semin Intervent Radiol       Date:  2012-09       Impact factor: 1.513

2.  Evaluation of endoscopic variceal ligation (EVL) versus propanolol plus isosorbide mononitrate/nadolol (ISMN) in the prevention of variceal rebleeding: comparison of cirrhotic and noncirrhotic patients.

Authors:  Shiv K Sarin; Manav Wadhawan; Rajesh Gupta; Hansa Shahi
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 3.  Current management of portal hypertension.

Authors:  Andrew S Wright; Layton F Rikkers
Journal:  J Gastrointest Surg       Date:  2005 Sep-Oct       Impact factor: 3.452

Review 4.  Transjugular intrahepatic portosystemic shunt.

Authors:  Kavish R Patidar; Malcolm Sydnor; Arun J Sanyal
Journal:  Clin Liver Dis       Date:  2014-08-27       Impact factor: 6.126

Review 5.  Nonendoscopic management strategies for acute esophagogastric variceal bleeding.

Authors:  Sanjaya K Satapathy; Arun J Sanyal
Journal:  Gastroenterol Clin North Am       Date:  2014-09-27       Impact factor: 3.806

Review 6.  The use and misuse of transjugular intrahepatic portasystemic shunts.

Authors:  A J Sanyal
Journal:  Curr Gastroenterol Rep       Date:  2000-02

7.  Early transjugular intrahepatic portosystemic shunt in US patients hospitalized with acute esophageal variceal bleeding.

Authors:  Basile Njei; Thomas R McCarty; Loren Laine
Journal:  J Gastroenterol Hepatol       Date:  2017-04       Impact factor: 4.029

8.  Antibiotic prophylaxis using third generation cephalosporins can reduce the risk of early rebleeding in the first acute gastroesophageal variceal hemorrhage: a prospective randomized study.

Authors:  Chung-Hwan Jun; Chang-Hwan Park; Wan-Sik Lee; Young-Eun Joo; Hyun-Soo Kim; Sung-Kyu Choi; Jong-Sun Rew; Sei-Jong Kim; Young-Dae Kim
Journal:  J Korean Med Sci       Date:  2006-10       Impact factor: 2.153

Review 9.  Why portal hypertensive varices bleed and bleed: a hypothesis.

Authors:  P A McCormick; S A Jenkins; N McIntyre; A K Burroughs
Journal:  Gut       Date:  1995-01       Impact factor: 23.059

Review 10.  Pharmacologic therapy for gastrointestinal bleeding due to portal hypertension and esophageal varices.

Authors:  Don C Rockey
Journal:  Curr Gastroenterol Rep       Date:  2006-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.